Randomized trial assessing impact of probiotic supplementation on gut microbiome and clinical outcome from targeted therapy in metastatic renal cell carcinoma

Cancer Medicine ◽

10.1002/cam4.3569 ◽

2020 ◽

Author(s):

Nazli Dizman ◽

JoAnn Hsu ◽

Paulo G. Bergerot ◽

John D. Gillece ◽

Megan Folkerts ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Clinical Outcome ◽

Randomized Trial ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Gut Microbiome ◽

Renal Cell ◽

Probiotic Supplementation

Download Full-text

Faculty Opinions recommendation of Clinical outcome in metastatic renal cell carcinoma patients after failure of initial vascular endothelial growth factor-targeted therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.3274959.2960057 ◽

2010 ◽

Author(s):

Keith Flaherty

Keyword(s):

Renal Cell Carcinoma ◽

Vascular Endothelial Growth Factor ◽

Targeted Therapy ◽

Growth Factor ◽

Clinical Outcome ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Vascular Endothelial ◽

Endothelial Growth Factor

Download Full-text

Clinical outcome of advanced and metastatic renal cell carcinoma treated with targeted therapy: is there a difference between young and old patients?

OncoTargets and Therapy ◽

10.2147/ott.s70012 ◽

2014 ◽

pp. 2043 ◽

Cited By ~ 5

Author(s):

Guiming Zhang ◽

Yao Zhu ◽

Dahai Dong ◽

Weijie Gu ◽

Hailiang Zhang ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Clinical Outcome ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Old Patients

Download Full-text

The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients

Targeted Oncology ◽

10.1007/s11523-012-0252-7 ◽

2013 ◽

Vol 8 (3) ◽

pp. 203-209 ◽

Cited By ~ 36

Author(s):

Mhd Y. Al-Marrawi ◽

◽

Brian I. Rini ◽

Lauren C. Harshman ◽

Georg Bjarnason ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Clinical Outcome ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Second Line ◽

First Line

Download Full-text

The association of clinical outcome to front-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma (mRCC) patients (Pts).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.4555 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 4555-4555 ◽

Cited By ~ 9

Author(s):

M. Y. Al-Marrawi ◽

B. I. Rini ◽

L. C. Harshman ◽

G. A. Bjarnason ◽

L. Wood ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Clinical Outcome ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Second Line ◽

Front Line

Download Full-text

Clinical Outcome in Metastatic Renal Cell Carcinoma Patients After Failure of Initial Vascular Endothelial Growth Factor-Targeted Therapy

Urology ◽

10.1016/j.urology.2009.12.031 ◽

2010 ◽

Vol 76 (2) ◽

pp. 430-434 ◽

Cited By ~ 63

Author(s):

Michael M. Vickers ◽

Toni K. Choueiri ◽

Miranda Rogers ◽

Andrew Percy ◽

Daygen Finch ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Vascular Endothelial Growth Factor ◽

Targeted Therapy ◽

Growth Factor ◽

Clinical Outcome ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Vascular Endothelial ◽

Endothelial Growth Factor

Download Full-text

Morphology, Attenuation, Size, and Structure (MASS) Criteria: Assessing Response and Predicting Clinical Outcome in Metastatic Renal Cell Carcinoma on Antiangiogenic Targeted Therapy

American Journal of Roentgenology ◽

10.2214/ajr.09.3456 ◽

2010 ◽

Vol 194 (6) ◽

pp. 1470-1478 ◽

Cited By ~ 168

Author(s):

Andrew Dennis Smith ◽

Shetal N. Shah ◽

Brian I. Rini ◽

Michael L. Lieber ◽

Erick M. Remer

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Clinical Outcome ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Size And Structure

Download Full-text

Faculty Opinions recommendation of Cabozantinib versus sunitinib as initial targeted therapy for patients with metastatic renal cell carcinoma of poor or intermediate risk: the alliance A031203 CABOSUN trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727316145.793548433 ◽

2018 ◽

Author(s):

Camilo Jimenez

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Intermediate Risk

Download Full-text

Faculty Opinions recommendation of The value of cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.9841956.10548054 ◽

2011 ◽

Author(s):

Axel Bex

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Cytoreductive Nephrectomy

Download Full-text

Therapeutic Drug Monitoring of Targeted Therapy in Metastatic Renal Cell Carcinoma

Protein and Peptide Letters ◽

10.2174/0929866525666180531073959 ◽

2018 ◽

Vol 25 (6) ◽

pp. 528-533

Author(s):

Dehua Liao ◽

Dangang Shangguan ◽

Dunwu Yao ◽

Qing Zhu ◽

Lizhi Cao ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Therapeutic Drug Monitoring ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Drug Monitoring ◽

Renal Cell ◽

Therapeutic Drug

Download Full-text

Sunitinib in Patients With Metastatic Renal Cell Carcinoma: Clinical Outcome According to International Metastatic Renal Cell Carcinoma Database Consortium Risk Group

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2018.04.005 ◽

2018 ◽

Vol 16 (4) ◽

pp. 298-304 ◽

Cited By ~ 18

Author(s):

Brian I. Rini ◽

Thomas E. Hutson ◽

Robert A. Figlin ◽

Maria Josè Lechuga ◽

Olga Valota ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Clinical Outcome ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Risk Group

Download Full-text